Skip to main content
Toggle navigation
Search
Home
Full Schedule
Home
Full Schedule
All Days
Thu, Oct 23
Fri, Oct 24
Sat, Oct 25
Full Schedule
Type here to filter the list
Saturday, October 25, 2025
7:00 AM – 8:00 AM
EDT
PME Breakfast Symposium (non-CME)
7:00 AM – 8:00 AM
EDT
PME Breakfast Symposium (non-CME)
PME Symposia (non-CME)
8:00 AM – 8:30 AM
EDT
Refresh and Recharge Break
8:00 AM – 8:30 AM
EDT
Refresh and Recharge Break
Short Break
8:30 AM – 8:35 AM
EDT
Opening Remarks
8:30 AM – 8:35 AM
EDT
Opening Remarks
Chair:
Christie M. Ballantyne, MD (he/him/his)
– Baylor College of Medicine
Session IV: Dyslipidemia/Atherosclerosis/Thrombosis
8:35 AM – 9:50 AM
EDT
Primetime CME Symposium Current and Emerging Therapeutics in Hyperlipidemia
8:35 AM – 9:50 AM
EDT
Primetime CME Symposium Current and Emerging Therapeutics in Hyperlipidemia
Speaker:
Pam R. Taub, MD, FACC
– UC San Diego
Speaker:
Pamela B. Morris, MD, FACC, FAHA, FASPC, FESC, FNLA (she/her/hers)
– The Medical University of South Carolina
Speaker:
Patrick M. Moriarty, MD, FACP, FACC, FNLA, FESC
– The University of Kansas Health System
Session IV: Dyslipidemia/Atherosclerosis/Thrombosis
CME Symposium
9:50 AM – 10:35 AM
EDT
Emerging Therapies in Dyslipidemia: Spotlight on CETP Inhibitors
9:50 AM – 10:35 AM
EDT
Emerging Therapies in Dyslipidemia: Spotlight on CETP Inhibitors
Speaker:
Erin D. Michos, MD, MHS (she/her/hers)
– Johns Hopkins University School of Medicine
Speaker:
Christie M. Ballantyne, MD (he/him/his)
– Baylor College of Medicine
Session IV: Dyslipidemia/Atherosclerosis/Thrombosis
10:35 AM – 11:05 AM
EDT
Refresh and Recharge
10:35 AM – 11:05 AM
EDT
Refresh and Recharge
Short Break
11:05 AM – 11:45 AM
EDT
FCS, MCS, Persistent Chylomicronemia, sHTG: What do we do now?
11:05 AM – 11:45 AM
EDT
FCS, MCS, Persistent Chylomicronemia, sHTG: What do we do now?
Speaker:
Christie M. Ballantyne, MD (he/him/his)
– Baylor College of Medicine
Session IV: Dyslipidemia/Atherosclerosis/Thrombosis
11:45 AM – 12:05 PM
EDT
Genetic Testing, Polygenic Risk Scores and Management of Cardiometabolic Disease
11:45 AM – 12:05 PM
EDT
Genetic Testing, Polygenic Risk Scores and Management of Cardiometabolic Disease
Speaker:
Pradeep Natarajan, MD, MMSc (he/him/his)
– Mass General Hospital
Session IV: Dyslipidemia/Atherosclerosis/Thrombosis
12:05 PM – 12:25 PM
EDT
Targeting Inflammation in CVD: What is the Right Approach?
12:05 PM – 12:25 PM
EDT
Targeting Inflammation in CVD: What is the Right Approach?
Speaker:
Paul M. Ridker, MD, MPH (he/him/his)
– Brigham and Women's Hospital
Session IV: Dyslipidemia/Atherosclerosis/Thrombosis
12:25 PM – 1:40 PM
EDT
Challenging Lipid Management Cases with Expert Panel Discussion and Audience Q&A
12:25 PM – 1:40 PM
EDT
Challenging Lipid Management Cases with Expert Panel Discussion and Audience Q&A
Moderator:
Christie M. Ballantyne, MD (he/him/his)
– Baylor College of Medicine
Panelist:
Erin D. Michos, MD, MHS (she/her/hers)
– Johns Hopkins University School of Medicine
Panelist:
Pradeep Natarajan, MD, MMSc (he/him/his)
– Mass General Hospital
Panelist:
Paul M. Ridker, MD, MPH (he/him/his)
– Brigham and Women's Hospital
Panelist:
Pam R. Taub, MD, FACC
– UC San Diego
Panelist:
Pamela B. Morris, MD, FACC, FAHA, FASPC, FESC, FNLA (she/her/hers)
– The Medical University of South Carolina
Panelist:
Patrick M. Moriarty, MD, FACP, FACC, FNLA, FESC
– The University of Kansas Health System
Session IV: Dyslipidemia/Atherosclerosis/Thrombosis
1:40 PM – 1:45 PM
EDT
Closing Remarks
1:40 PM – 1:45 PM
EDT
Closing Remarks
Chair:
Christie M. Ballantyne, MD (he/him/his)
– Baylor College of Medicine
Session IV: Dyslipidemia/Atherosclerosis/Thrombosis
